Australia invests $30 M to support vital brain and mental health research
Therapeutics | News | 0 Comment | 19 Aug, 2022
Monash University has received a $30 million philanthropic gift that will fund vital mental health research and preventa...Read more
Frontier Biotechnologies proposes treatments for acute and prolonged COVID
Therapeutics | News | 0 Comment | 15 Aug, 2022
China-headquartered global biopharmaceutical company Frontier Biotechnologies announced positive results from the Phase ...Read more
Australia investigates how to stop painful chemo for kids
Therapeutics | News | 0 Comment | 12 Aug, 2022
Stopping children undergoing chemotherapy from feeling pain and other debilitating side-effects is the focus of research...Read more
Therapeutics | Opinion | By Hithaishi C Bhaksar | 2 Comment | 11 Aug, 2022
A surge in pharmaceutical R&D has led to an increase in the number of Cell & Gene Therapy (CGT) candidates being...Read more
India to pioneer next-generation snakebite therapy
Therapeutics | News | 0 Comment | 09 Aug, 2022
Bharat Serums and Vaccines (BSV), a leading biopharmaceutical company in India, has announced a meaningful collaboration...Read more
Korea develops new therapeutic drug for Alzheimer’s disease
Therapeutics | News | 0 Comment | 09 Aug, 2022
Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA app...Read more
Griffith University launches two cancer research centres with $4.6 M funding
Therapeutics | News | 0 Comment | 09 Aug, 2022
Griffith University has launched two cancer research centres backed by $4.6 million in funding from the Australian Cance...Read more
New Zealand takes significant step on path to developing Alzheimer’s therapy
Therapeutics | News | 0 Comment | 05 Aug, 2022
A brain protein with high potential to delay or reverse the onset of Alzheimer’s disease has been exploited by New...Read more
Singapore develops new compounds to kill multi drug-resistant TB
Therapeutics | News | 0 Comment | 04 Aug, 2022
With multi drug-resistant tuberculosis (TB) causing outbreaks in both developing and developed nations, new treatments a...Read more
Singapore turns aquaculture waste into new biomaterial for tissue repair
Therapeutics | News | 0 Comment | 01 Aug, 2022
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new biomaterial made entirely...Read more
NTU Singapore wins S$2.8 M grant for antiviral drug research
Therapeutics | News | 0 Comment | 26 Jul, 2022
A team of scientists led by Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapo...Read more
New Zealand provides hope for better cerebral palsy outcomes
Therapeutics | News | 0 Comment | 25 Jul, 2022
A pair of researchers at the University of Auckland in New Zealand has led a successful bid to trial regional hubs for d...Read more
New discovery in cancer progression paves way to combat cancer
Therapeutics | News | 0 Comment | 20 Jul, 2022
Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS), a...Read more
Discovery by Australia boosts hopes of preventing Type I diabetes
Therapeutics | News | 0 Comment | 18 Jul, 2022
Australian researchers may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could...Read more
Singapore develops drug molecule for treating atrial fibrillation
Therapeutics | News | 0 Comment | 18 Jul, 2022
Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceuti...Read more
Hong Kong links non-invasive eye stimulation with depression and dementia
Therapeutics | News | 0 Comment | 08 Jul, 2022
A joint research team from Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) and City ...Read more
Australia uncovers driving forces of Alzheimer’s disease
Therapeutics | News | 0 Comment | 08 Jul, 2022
Alzheimer’s disease, the most common form of dementia, currently has no cure or effective therapy, in part due to ...Read more
MiRXES launches world’s first research project for a multi-cancer screening test
Therapeutics | News | 0 Comment | 07 Jul, 2022
MiRXES Pte Ltd, (HQ: Singapore) has launched the world’s first large-scale clinical research Project, CADENC...Read more